Inactive Instrument

Company Cell MedX Corp. Other OTC

Equities

CMXC

US15115X1072

Biotechnology & Medical Research

Business Summary

Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.

Sales per Business

USD in Million2022Weight2023Weight Delta
Monthly Subscriptions
58.8 %
0 60.6 % 0 58.8 % -55.85%
eBalance Devices
41.2 %
0 39.4 % 0 41.2 % -52.33%

Sales per region

USD in Million2022Weight2023Weight Delta
Canada
100.0 %
0 100.0 % 0 100.0 % -54.46%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 12/12
Director of Finance/CFO 46 24/14/24
Chairman 76 23/18/23
Director/Board Member 59 08/20/08
Director/Board Member 63 27/22/27

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 54 12/12
Director/Board Member 63 27/22/27
Director/Board Member 59 08/20/08
Chairman 76 23/18/23
Director/Board Member 55 12/12
Director of Finance/CFO 46 24/14/24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 297,236,373 60,447,694 ( 20.34 %) 0 20.34 %

Shareholders

NameEquities%Valuation
88,959,726 29.93 % 3 M $
64,855,148 21.82 % 2 M $
25,639,897 8.626 % 820 477 $
Clementine Tang
8.287 %
24,631,939 8.287 % 788 222 $
Sam Ahdoot
8.088 %
24,039,142 8.088 % 769 253 $
5,341,855 1.797 % 170 939 $
2,056,687 0.6919 % 65 814 $
1,214,285 0.4085 % 38 857 $
50,000 0.0168 % 1 600 $

Company contact information

Cell MedX Corp.

820 - 1130 Pender Street

V6E 4A4, West Vancouver

+844 238 2692

http://www.cellmedx.com
address Cell MedX Corp.(CMXC)